- $2.28bn
- $1.14bn
- $742.44m
- 73
- 84
- 71
- 89
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 481 | 470 | 505 | 595 | 690 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 483 | 470 | 505 | 592 | 649 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 263 | 219 | 233 | 300 | 325 |
Provision for Income Taxes | |||||
Net Income After Taxes | 210 | 173 | 184 | 236 | 257 |
Net Income Before Extraordinary Items | |||||
Net Income | 210 | 173 | 184 | 236 | 257 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 210 | 173 | 174 | 222 | 243 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.61 | 2.69 | 2.54 | 3.39 | 3.76 |
Dividends per Share |